Retatrutide appears to be a new medication in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By stimulating these receptors, https://stevezxms978623.humor-blog.com/34957356/retatrutide-a-promising-new-treatment-for-obesity